With 1.76 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.77 million shares. The 52-week range on GLYC shows that it touched its highest point at $0.63 and its lowest point at $0.14 during that stretch. It currently has a 1-year price target of $0.50. Beta for the stock currently stands at 1.58.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GLYC was down-trending over the past week, with a drop of -20.95%, but this was down by -35.36% over a month. Three-month performance dropped to -35.91% while six-month performance fell -43.63%. The stock lost -35.51% in the past year, while it has lost -33.33% so far this year. A look at the trailing 12-month EPS for GLYC yields -0.46 with Next year EPS estimates of -0.03. For the next quarter, that number is 0.00. This implies an EPS growth rate of 96.61% for this year and -50.00% for next year. EPS is expected to grow by 62.95% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 15.18%.
Float and Shares Shorts:
At present, 64.53 million GLYC shares are outstanding with a float of 56.12 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GLYC since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.51 being high and -$0.51 being low. For GLYC, this leads to a yearly average estimate of -$0.51.
